1. Xu, Yangheng, Hong, Zhisheng, Yu, Sheng, Xie, Sisi, Zhu, Lvyun. 2024. Fresh Insights Into SLC25A26: Potential New Therapeutic Target for Cancers: A Review. In Oncology reviews, 18, 1379323. doi:10.3389/or.2024.1379323. https://pubmed.ncbi.nlm.nih.gov/38745827/
2. Cheng, Gui-Ping, Guo, Shi-Meng, Yin, Ying, He, Ximiao, Zhou, Li-Quan. 2022. Aberrant Expression of Mitochondrial SAM Transporter SLC25A26 Impairs Oocyte Maturation and Early Development in Mice. In Oxidative medicine and cellular longevity, 2022, 1681623. doi:10.1155/2022/1681623. https://pubmed.ncbi.nlm.nih.gov/35464759/
3. Schober, Florian A, Tang, Jia Xin, Sergeant, Kate, Freyer, Christoph, Wredenberg, Anna. . Pathogenic SLC25A26 variants impair SAH transport activity causing mitochondrial disease. In Human molecular genetics, 31, 2049-2062. doi:10.1093/hmg/ddac002. https://pubmed.ncbi.nlm.nih.gov/35024855/
4. Cianciulli, Antonia, Menga, Alessio, Ferdinando, Palmieri, Iacobazzi, Vito. 2018. FOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cells. In Biochimie, 154, 25-34. doi:10.1016/j.biochi.2018.07.025. https://pubmed.ncbi.nlm.nih.gov/30076902/
5. Menga, Alessio, Palmieri, Erika M, Cianciulli, Antonia, Castegna, Alessandra, Iacobazzi, Vito. 2017. SLC25A26 overexpression impairs cell function via mtDNA hypermethylation and rewiring of methyl metabolism. In The FEBS journal, 284, 967-984. doi:10.1111/febs.14028. https://pubmed.ncbi.nlm.nih.gov/28118529/
6. Kishita, Yoshihito, Pajak, Aleksandra, Bolar, Nikhita Ajit, Okazaki, Yasushi, Wedell, Anna. 2015. Intra-mitochondrial Methylation Deficiency Due to Mutations in SLC25A26. In American journal of human genetics, 97, 761-8. doi:10.1016/j.ajhg.2015.09.013. https://pubmed.ncbi.nlm.nih.gov/26522469/
7. Shi, P, Cheng, Y P, Li, Z Y, Gao, L, Xu, C. . [Identification and functional analysis of combined oxidative phosphorylation deficiency 28 gene mutation]. In Zhonghua nei ke za zhi, 61, 1324-1329. doi:10.3760/cma.j.cn112138-20211208-00875. https://pubmed.ncbi.nlm.nih.gov/36456512/
8. Rosenbaum, Adam, Dahlin, Anna M, Andersson, Ulrika, Wibom, Carl, Melin, Beatrice. 2023. Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines. In Scientific reports, 13, 6777. doi:10.1038/s41598-023-33923-4. https://pubmed.ncbi.nlm.nih.gov/37185361/
智鼠故事 
